Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trial
Authors:
- the EMC Study GroupTGthe EMC Study Group
- André TadićATAndré Tadić
- Stanislav GorbulevSGStanislav Gorbulev
- Norbert DahmenNDNorbert Dahmen
- Christoph HiemkeChristoph Hiemke
- Dieter F BrausDBDieter F Braus
- Joachim RöschkeJRJoachim Röschke
- Dietrich van CalkerDCDietrich van Calker
- Daniel WachtlinDWDaniel Wachtlin
- Kai KronfeldKKKai Kronfeld
- Thorsten GorbauchTGThorsten Gorbauch
- Monika Seibert-GrafeMSMonika Seibert-Grafe
Open Access
- 26 February 2010
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 11 (1) , 21
Abstract
In Major Depressive Disorder (MDD), the traditional belief of a delayed onset of antidepressants' effects has lead to the concept of current guidelines that treatment durations should be between 3-8 weeks before medication change in case of insufficient outcome. Post hoc analyses of clinical trials, however, have shown that improvement usually occurs within the first 10-14 days of treatment and that such early improvement (Hamilton Depression Rating Scale [HAMD] decrease ≥20%) has a substantial predictive value for final treatment outcome. Even more important, non-improvement (HAMD decrease <20%) after 14 days of treatment was found to be highly predictive for a poor final treatment outcome.Keywords
This publication has 39 references indexed in Scilit:
- Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine studySchizophrenia Research, 2008
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLOS Medicine, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Acceleration and Augmentation of Antidepressants With Lithium for Depressive DisordersThe Journal of Clinical Psychiatry, 2007
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareThe World Journal of Biological Psychiatry, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant ActionArchives of General Psychiatry, 2006
- Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatrica Scandinavica, 2004
- The Economic Burden of Depression in the United StatesThe Journal of Clinical Psychiatry, 2003
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987